Acne VulgarisNCT01050465
MedlinePlus Health Prescriptions: Developing a Pragmatic Approach for Clinic Use
A study testing health information prescription in people with Acne Vulgaris and Allergic Rhinitis, run by University of Missouri-Columbia.
Trial summary
The specific aim of this proposed pilot study is to compare two standardized processes (paper and electronic) to deliver a customized MedlinePlus health information prescription. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Acne Vulgaris, Allergic Rhinitis, Anxiety
- What is being tested?
- health information prescription
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 907 participants
- Where
- No sites listed yet
- Study dates
- May 2009to Dec 2010
- Phase
- Interventional
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- one of the 40 target health conditions.
Who cannot join
- absence of at least one of the target 40 conditions
About this study
Official title: MedlinePlus Health Prescriptions: Developing a Real World Approach for Clinic Use
The specific aim of this proposed pilot study is to compare two standardized processes (paper and electronic) to deliver a customized MedlinePlus health information prescription.
Read the detailed description
The specific aim of this proposed pilot study is to compare two standardized processes (paper and electronic) to deliver a customized MedlinePlus health information prescription.
Primary Hypothesis. Individuals in the paper prescription group will be just as likely to seek information using MedlinePlus compared with individuals in the group who receive the same customized information through an email prescription.
Secondary Hypothesis. Individuals in the paper prescription group will be just as likely to have successful behavioral outcome measures as those in the group who receive the same customized information through an email prescription.
- Conditions
- Acne Vulgaris, Allergic Rhinitis, Anxiety, Asthma, Back Pain, Prostatic Hyperplasia
- Being tested
- health information prescription
- Keywords
- HIV, Knee pain, Colonoscopy, Mammography, Vaccination
- Medical subject headings
- Acne Vulgaris, Rhinitis, Allergic, Anxiety Disorders, Asthma, Back Pain, Prostatic Hyperplasia, Bursitis, Pulmonary Disease, Chronic Obstructive
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
health information prescriptionOther
Patients randomized to the email arm will receive a health information prescription via email on a health care topic following their clinic visit. Patients randomized to the paper arm will receive a health information prescription on paper on a health care topic following their clinic visit.
| Study group | Role | What they receive |
|---|---|---|
| Active comparator | Patients randomized to this arm will receive an email health information prescription. Receives: Other: health information prescription | |
| paper | Active comparator | Patients randomized to this arm will receive a paper health information prescription. Receives: Other: health information prescription |
What is being measured
The primary outcome is the main question the study is designed to answer.
seeking information using MedlinePlus
Measured: clicks will be tracked on the website when they occur
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted15 Jan 2010 (estimated)
- Study startMay 2009
- Primary completionOct 2010
- Study completionDec 2010
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Acne VulgarisStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 907 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Missouri-Columbia
- Sponsor type
- University, hospital or other
- Collaborators
- National Library of Medicine (NLM)
- Responsible party
- Sponsor
- Investigators
- Robert Hodge, MD, Principal investigator, University of Missouri-Columbia
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01050465
- Sponsor's protocol ID
- HHSN276200800445P
- Status last verified
- Sep 2016
- First submitted
- 13 Jan 2010
- Last updated
- 30 Sep 2016
- Results posted
- No
- Data monitoring committee
- No
- Individual data sharing
- No
Publications
Coberly E, Boren SA, Mittal M, Davis JW, Scoville C, Chitima-Matsiga R, Ge B, Cullina A, Logan RA, Steinmann WC, Hodge RH. MedlinePlus-based health information prescriptions: a comparison of email vs paper delivery. Inform Prim Care. 2012;20(3):197-205. doi: 10.14236/jhi.v20i3.25.
PubMed 23710844